A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
Ang, Yvonne L. E., Ho, Gwo Fuang, Soo, Ross A., Sundar, Raghav, Tan, Sing Huang, Yong, Wei Peng, Ow, Samuel G. W., Lim, Joline S. J., Chong, Wan Qin, Soe, Phyu Pyar, Tai, Bee Choo, Wang, Lingzhi, Goh,Volume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07616-4
Date:
December, 2020
File:
PDF, 1.29 MB
2020